Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation
Open Access
- 4 March 2005
- journal article
- Published by Springer Nature in Respiratory Research
- Vol. 6 (1)
- https://doi.org/10.1186/1465-9921-6-23
Abstract
Background Recent evidence suggests that endogenous arginase activity potentiates airway responsiveness to methacholine by attenuation of agonist-induced nitric oxide (NO) production, presumably by competition with epithelial constitutive NO synthase for the common substrate, L-arginine. Using guinea pig tracheal open-ring preparations, we now investigated the involvement of arginase in the modulation of neuronal nitric oxide synthase (nNOS)-mediated relaxation induced by inhibitory nonadrenergic noncholinergic (iNANC) nerve stimulation. Methods Electrical field stimulation (EFS; 150 mA, 4 ms, 4 s, 0.5 – 16 Hz)-induced relaxation was measured in tracheal preparations precontracted to 30% with histamine, in the presence of 1 μM atropine and 3 μM indomethacin. The contribution of NO to the EFS-induced relaxation was assessed by the nonselective NOS inhibitor L-NNA (0.1 mM), while the involvement of arginase activity in the regulation of EFS-induced NO production and relaxation was investigated by the effect of the specific arginase inhibitor nor-NOHA (10 μM). Furthermore, the role of substrate availability to nNOS in EFS-induced relaxation was measured in the presence of various concentrations of exogenous L-arginine. Results EFS induced a frequency-dependent relaxation, ranging from 6.6 ± 0.8% at 0.5 Hz to 74.6 ± 1.2% at 16 Hz, which was inhibited with the NOS inhibitor L-NNA by 78.0 ± 10.5% at 0.5 Hz to 26.7 ± 7.7% at 8 Hz (P < 0.01 all). In contrast, the arginase inhibitor nor-NOHA increased EFS-induced relaxation by 3.3 ± 1.2-fold at 0.5 Hz to 1.2 ± 0.1-fold at 4 Hz (P < 0.05 all), which was reversed by L-NNA to the level of control airways in the presence of L-NNA (P < 0.01 all). Similar to nor-NOHA, exogenous L-arginine increased EFS-induced airway relaxation (P < 0.05 all). Conclusion The results indicate that endogenous arginase activity attenuates iNANC nerve-mediated airway relaxation by inhibition of NO generation, presumably by limiting L-arginine availability to nNOS.Keywords
This publication has 26 references indexed in Scilit:
- Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides.American Journal of Respiratory and Critical Care Medicine, 1996
- NADPH-diaphorase activity as a marker for nitric oxide synthase in neurons of the guinea pig respiratory tract.American Journal of Respiratory and Critical Care Medicine, 1994
- Inhibition byl-NG-Nitro-l-Arginine of Nonadrenergic-Noncholinergic-mediated Relaxations of Human Isolated Central and Peripheral AirwaysAmerican Review of Respiratory Disease, 1992
- Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humansEuropean Journal of Pharmacology, 1992
- Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airwaysEuropean Journal of Pharmacology, 1991
- Evidence that part of the NANC relaxant response of guinea‐pig trachea to electrical field stimulation is mediated by nitric oxideBritish Journal of Pharmacology, 1991
- l‐NG‐nitro arginine inhibits non‐adrenergic, non‐cholinergic relaxations of guinea‐pig isolated tracheal smooth muscleBritish Journal of Pharmacology, 1990
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non‐adrenergic, non‐cholinergic relaxations of tracheal smooth muscleBritish Journal of Pharmacology, 1989
- Effects of peptidases on non‐adrenergic, non‐cholinergic inhibitory responses of tracheal smooth muscle: a comparison with effects on VIP‐ and PHI‐induced relaxationBritish Journal of Pharmacology, 1989